EDP Sciences logo
Search
Menu
All issues Volume 44 / No 3 (May-June 2004) Reprod. Nutr. Dev., 44 3 (2004) 273-282 References
Free Access
Issue
Reprod. Nutr. Dev.
Volume 44, Number 3, May-June 2004
Page(s) 273 - 282
DOI https://doi.org/10.1051/rnd:2004034
References of Reprod. Nutr. Dev. 44 273-282
  1. Folsom AR, Ma J, Aggovern PG, Eckfeldt JH. Relation between plasma phospholipid saturation fatty acids and hyperinsulinemia. Metabolism 1996, 25: 223-228.
  2. Ma J, Folsom R, Lewis L, Eckfeldt H. Relation of plasma phospholipids and cholesterol ester fatty acid composition to carotid artery intima-media thickness: the atherosclerosis risk in communities (ARIC) study. Am J Clin Nutr 1997, 65: 551-559.
  3. De Lacruz JP, Villalobos MA, Carmona JA, Romero M, Agreda JM, de Lacuesta F. Antithrombotic potential of olive oil administration in rabbits with elevated cholesterol. Thromb Res 2000, 100: 305-315.
  4. Roche HM. Unsaturated fatty acids. Proc Nutr Soc 1999, 58: 397-401.
  5. Spector A. Essentiality of fatty acids. Lipids 1999, 34: S1-S3.
  6. Connor WE. $\alpha$-linolenic acid in health and disease. Am J Clin Nutr 1999, 69: 827-828.
  7. Horrobin DF. Fatty acid metabolism in health and disease: the role of $\Delta$6-desaturase. Am J Clin Nutr 1993, 57S: 732S-736S.
  8. Leaf A, Weber P. Cardiovascular effects of n-3 fatty acids. N Engl J Med 1998, 318: 549-557.
  9. Connor W, Nevringer M, Resbick S. Essential fatty acids: the importance of n-3 fatty acids in the retina and brain. Nutr Rev 1992, 50: 21-29.
  10. North JA, Spector A, Buettner GR. ORTH Cell fatty acid composition affects free radical formation during lipid peroxidation. Am J Physiol 1994, 267: CI77-CI188.
  11. Jump DB, Claarke SD, Thelen A, Liimatta M, Ren B, Badin R. Dietary polyunsaturated fatty acid regulation of gene expression. Prog Lipid Res 1996, 35: 227-241.
  12. Rotstein NP, Aveldano ML, Barrantes FJ, Roccamo AM, Politi LE. Apoptosis of retinal photoreceptors during development in vitro: protective effect of docosahexaenoic acid. J Neurochem 1997, 69: 504-513.
  13. Romon M, Nuttens MC, Theret N, Delbart C, Lecerf JM, Fruchart JC, Salomez JL. Comparison between fat intake assessed by a 3-day food record and phospholipid fatty acid composition of red blood cells. Metab Clin Exp 1995, 44: 1139-1145.
  14. Brown AJ, Robert DCK. Erythrocyte EPA as a marker for intake of fish and fish oil. Eur J Clin Nutr 1990, 44: 487-488.
  15. Parra MS, Schnaas L, Meydani M, Perroni E. Erythrocyte cell membrane phospholipids levels compared against reported dietary intakes of polyunsaturated fatty acids in pregnant Mexican women. Public Health Nutrition 2002, 5: 931-937.
  16. Pawlosky R, Hibben J, Wegher B, Sebring N, Salem J. The effects of cigarette smoking on the metabolism of essential fatty acids. Lipids 1999, 34: S287.
  17. Berry C, Montgomery C, Sattar N, Norrie J, Weaver LT. Fatty acid status of women of reproductive age. Eur J Clin Nutr 2001, 55: 518-524.
  18. Matorras R, Perteagudo L, Sanjurjo P, Ruiz J. The intake of long chain n-3 PUFA during pregnancy and their levels in the mother influence the new-born levels. Eur J Obstet Gynecol Reprod Biol 1999, 83: 179-189.
  19. Wang Y, Kay H, Killian AP. Decreased levels of polyunsaturated fatty acids in preeclampsia. Am J Obstet Gynecol 1991, 164: 812-819.
  20. Sattar N, Berry C, Greer I. Essential fatty acids in relation to pregnancy complications and fetal development. Br J Obstet Gynecol 1998, 105: 1248-1255.
  21. Matorras R, Ruiz J, Perteagudo L, Barbazan MJ, Diaz A, Velladoid A, Sanjurjo P. Longitudinal study of fatty acids in plasma and erythrocyte phospholipids during pregnancy. J Perinat Med 2001, 29: 293-297.
  22. Harel Z, Biro FM, Kottenhahn RK, Rosenthal S. Supplementation with omega-3 polyunsaturated fatty acids in the management of dysmenorrhea in adolescents. Am J Obstet Gynecol 1996, 174: 1335-1338.
  23. Deutch B. Menstrual pain in Danish women correlated with low n-3 polyunsaturated fatty acid intake. Eur J Clin Nutr 1995, 49: 568-516.
  24. Drevon CA. Marine oils and their effects. Nutr Rev 1992, 50: 38-45.
  25. Sigel EN, Lerlan RH. Altered fatty acids metabolism in patients with angiographically documented coronary artery disease. Metabolism 1994, 43: 982-993.
  26. Simopoulos AP. Essential fatty acids in health and chronic disease. Am J Clin Nutr 1999, 70S: 560S-569S.
  27. Albert CM. Blood levels of long chain n-3 acids and the risk of sudden death. N Engl J Med 2002, 15: 1113-1118.
  28. Weber P, Raederstorff D. Triglyceride-lowering affect of omega 3 LC polyunsaturated fatty acids. A review. Nutr Metab Cardiovasc Dis 2000, 10: 28-37.
  29. Williams R, Hunt SC, Hasstedt SJ. Hypertension: genetics and nutrition. In: Simopoulous AP, Childs B (Eds), Genetic variation and nutrition. World Rev Nutr Diet 1990, 63: 116-130 [PubMed].
  30. Berry EM, Hirsch J. Does dietary linoleic acid influence blood pressure? Am J Clin Nutr 1986, 44: 336-340.
  31. Berry EM, Hirsch J. Does dietary linoleic acid influence blood pressure? Am J Clin Nutr 1986, 44: 336-340.
  32. Bonaa KH, Bjerve KS, Straum B, Gram IT, Thelle D. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. A population-based intervention trial from the tromso study. N Engl J Med 1990, 322: 795-801.
  33. Field CJ, Ryan EA, Thomson AB, Clandinin MT. Diet fat composition alters membrane phospholipids composition, insulin binding, and glucose metabolism in adipocytes from control and diabetic animals. J Biol Chem 1990, 265: 11143-11150 [PubMed].
  34. Pelikanova T, Kohout M, Valek J, Base J, Kazdova L. Insulin secretion and insulin action related to the serum phospholipid fatty acid pattern in healthy men. Metabolism 1989, 38: 188-192.
  35. Clifton PM, Nestel PJ. Relationship between plasma insulin and erythrocyte fatty composition. Prostaglandins Leukot Essent Fat Acids 1998, 59: 191-194.
  36. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV. The relation between insulin sensitivity and the fatty acid composition of skeletal-muscle phospholipids. N Engl J Med 1993, 328: 238-244.
  37. Miller A, Berrino F, Hill M, Pietnen P, Piboli E, Wahrendorf J. Diet in the aetiology of cancer: a review. Eur J Cancer 1990, 30: 207-220.
  38. Willet WC. Diet and health: what should we eat? Science 1994, 264: 532-537.
  39. Rose DP. Dietary fatty acids and cancer. Am J Nutr 1997, 66S: 998-1003.
  40. Byers T, Gieseker K. Issues in the design and interpretation of studies of fatty acids and cancer in humans. Am J Clin Nutr 1997, 66S: 1541-1547.
  41. Caroll K. The role of dietary in breast cancer. Curr Opin Lipidol 1997, 8: 53-56.
  42. Pariza M. Animal studies: summary, gaps, and future research. Am J Clin Nutr 1997, 66S: 1539-1540.
  43. Das UN. Reversal of tumor cell drug resistance by essential fatty acids. Lipids 1999, (Suppl) 34: 103.
  44. Bougnoux P, Germain E, Lavillonière F, Cognalult S, Jourdan ML, Chajes V, Lhuillery C. Polyunsaturated fatty acids and breast cancer. Lipids 1999, 34: S99.
  45. Kobayashi M, Sasaki S, Hamada G, Tsugane S. Serum n-3 fatty acids, fish consumption and cancer mortality in six Japanese population in Japan and Brasil. Jpn J Cancer Res 1999, 90: 914-921 [PubMed].
  46. Bordoni A, Biagi P, Masi P. Evening primrose oil (Efanol) in the treatment of children with atopic eczema. Drugs Exp Clin Res 1987, 14: 291-297.
  47. Manku MS, Horrobin DF, Morse NL. Essential fatty acids in the plasma phospholipids of patients with atopic eczema. Br J Dermatol 1984, 110: 643-648.
  48. Hibbeln JR, Salem N. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr 1995, 62: 1-9.
  49. Oliewiecki S, Burton JL, Elles K, Horrobin DF. Levels of essential and other fatty acids in plasma and red cell phospholipid from normal controls and patients with atopic eczema. Acta Derm Venoral 1990, 71: 224-228.
  50. Ziboh VA. n-3 polyunsaturated fatty acids constituents of fish oil and the management if skin inflammatory and scaly disorders. World Rev Nutr Diet 1991, 66: 425-435.
  51. Kremer JM. Effects of modulation of inflammatory and immune parameters in patients with rheumatic and inflammatory disease receiving dietary supplementation of n-3 and n-6 fatty acids. Lipids 1996, 31: S243-S247.
  52. Simopoulos AP. Omega-3 fatty acids in inflammation and auto-immune disease. J Am Coll Nutr 2002, 21: 495-505.
  53. Leventhal LJ, Boyce EG, Zurier RB. Treatment of rheumatoid arthritis with gammalinolenic acid. Ann Intern Med 1993, 119: 867-873.
  54. Santoli D, Philips PD, Zurier RB. Suppression of interleukine-2 dependant human T cell growth by prostaglandin E and their precursor fatty acids. J Clin Invest 1990, 85: 424-432.
  55. Guesens P, Wouters C, Nijs J, Jiang Y, De Queker J. Long-term effect of n-3 fatty acid supplementation in active rheumatoid arthritis. A 12 month double blind controlled study. Arth Rhum 1994, 37: 824-829.
  56. Stenson WF, Cort D, Beeken W, Rodgers J, Burakoff R. Trial of fish oil supplemented diet in ulcerative colitis. Word Rev Nutr Diet 1991, 66: 533.
  57. Beluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M. Effect of an enteric coated fish oil preparation on relapses in Crohn's disease. N Engl J Med 1996, 334: 1557-1560.
  58. Chambrier C, Garcia I, Bannier E, Boncompain M, Bouletreau P. Specific changes in n-6 fatty acid metabolism in patients with chronic intestinal failure. Clin Nutr 2002, 21: 67-72.
  59. Rogiers V, Crockaert R, Vis HL. Altered phospholipid composition and changed fatty acid pattern of the various phospholipid fractions of red cell membranes of cystic fibrosis children with pancreatic insufficiency. Clin Chim Acta 1980, 105: 105-115.
  60. Hubard VS, Dunn GD. Fatty acid composition of erythrocyte phospholipids from patients with cystic fibrosis. Clin Chim Acta 1980, 102: 115-118.
  61. Christophe A, Robberecht E. Directed modification instead of normalization of fatty acid patterns in cystic fibrosis: an emerging concept. Curr Opin Clin Nutr Metab Care 2001, 4: 111-113.
  62. Cunnane S, Ho S, Dore-Duffy P, Elis K, Horrobin D. Essential fatty acids and lipid profiles in plasma and erythrocytes in patients with multiple sclerosis. Am J Clin Nutr 1989, 50: 801-806.
  63. Bates D, Cartlidge N, French JM, Jackson MJ, Nightingale S, Sinclair HM. A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis. J Neurol Neurosurg Psychiatry 1989, 52: 18-22.
  64. Swank RL, Dugan BB. Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet 1990, 336: 37-39.
  65. Wainwright P. Do essential fatty acids play a role in brain and behavioural development? Neurosci Biobehav Rev 1992, 16: 193-205.
  66. Kyle DJ, Shaeter E, Patton G, Beiser A. Low serum docosahexaenoic acid is a significant risk for Alzheimer's dementia. Lipids 1999, 34: S245.
  67. Peet M, Murphy B, Shay J, Horrobin D. Depletion of omega-3 fatty acid levels of depressive patients. Biol Psychiatry 1998, 43: 315-319.
  68. Adams PB, Sinclair AJ, Lawson S, Sanigorski A. Arachidonic acid to eicosapentaenoic acid ratio in blood correlate positively with clinical symptoms of depression. In: abstract book 2nd International Congress of the International Society Study Fatty acids and Lipids, Bethesda, 1995.
  69. Castellanos FX. Toward a pathophysiology of attention-deficit/hyperactivity disorder. Clin Pediatr 1997, 36: 381-393.
  70. Stevens LJ, Zentall SS, Deck JL, Abate ML, Watkins BA, Lipp SR, Burges JR. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am J Clin Nutr 1995, 62: 761-768.
  71. Fenton WS, Hibbelin JR, Knable M. Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia. Biol Psychiatry 2000, 47: 8-21.
  72. Assies J, Lieverse R, Vreken P, Wanders RJ, Dingemans PM, Linszen DH. Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group. Biol Psychiatry 2001, 6: 510-522.
  73. Peet M, Brind J, Ramchand CN, Shah S, Vankar KG. Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia. Schizoph Res 2001, 49: 243-251.
  74. Peet M, Laugharne J, Rangarajan N, Horrobin D, Reynolds G. Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients. J Psychiatr Res 1995, 29: 227-232.
  75. Yao JK, Van Kammen DP, Gurkis J. Red blood cell membrane dynamics in schizophrenia. Correlation of fatty acid abnormalities with clinical measures. Schizophr Res 1994, 13: 227-232.
  76. Gen AI, Glen EM, Horrobin DF, Vaddali KS, Spellman M, Morse-Fisher N. A red cell membrane abnormality in a subgroup of schizophrenic patients : evidence for two diseases. Schizoph Res 1994, 12: 53-61.
  77. Peet M, Laugharne JD, Horrobin DF, Reynolds GP. Arachidonic acid: a common link in the biology of schizophrenia? Arch Gen Psychiatry 1994, 51: 665-666.
  78. Norrish A, Skeaff C, Arribas G, Jackson R. Prostate cancer risk and consumption of fish oils: dietary biomarker-based case-control study. Br J Cancer 1999, 81: 1238-1242.
  79. Nightingale S, Woo E, Smith AD, French JM, Gale MM, Sinclair HM, Bates D, Shaw DA. Red blood cell and adipose tissue fatty acids in mild inactive multiple sclerosis. Acta Neurol Scand 1990, 82: 43-50.